Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1. (2016)

First Author: Watson HA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/icb.2016.45

PubMed Identifier: 27430370

Publication URI: http://europepmc.org/abstract/MED/27430370

Type: Journal Article/Review

Volume: 94

Parent Publication: Immunology and cell biology

Issue: 8

ISSN: 0818-9641